Cancer

An increase in the demand for pleural catheters from surgeons, pulmonologists and physicians on the back of pleural catheters’ ability to provide effective fluid control with minimal risk. Projecting the market growth at a healthy CAGR of 6.4%, a new market study of Fact.MR provides an inclusive analysis of the pleural catheters market. This growth is further complemented by the increasing adoption of pleural catheters coupled with reduced hospitalization.

Pleural Catheters Market – Key Takeaways

Malignant pleural effusion will remain the top indication type, with three-quarters of revenue share, owing to frequent utilization of clinical management of both malignant and benign effusion.
Owing to the availability of pleural catheters and skilled personnel for better clinical management of patients, hospitals account for 2/3rd of overall market value.
Developed regional markets collectively account for more than 60%, on the back of rising elderly population and increase in accessibility to healthcare facilities.
An increase in the prevalence of COPD and the expansion of private hospitals in rural areas are boosting the demand for pleural catheters in Asia Pacific.
Request for Sample detailed COVID-19 impact analysis on the Market @ https://www.factmr.com/connectus/sample?flag=S&rep_id=3128 

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Cancer Biomarkers market during the historical period of 2015 – 2019. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2020, and key prospects over the forecast period 2020 – 2025.

The global cancer biomarkers market is anticipated to grow at a staggering CAGR of 12.2% during the forecast period (2020-2025). Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Cancer Biomarkers market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Cancer Biomarkers market.

After reading the Cancer Biomarkers market report, readers get insight into: 

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Cancer Biomarkers market during the historical period of 2015 – 2019. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2020, and key prospects over the forecast period 2020 – 2025. 

The global cancer biomarkers market is anticipated to grow at a staggering CAGR of 12.2% during the forecast period (2020-2025). Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Cancer Biomarkers market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Cancer Biomarkers market. 

After reading the Cancer Biomarkers market report, readers get insight into: 

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Cancer Immunotherapy market during the historical period of 2013 – 2019. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2020, and key prospects over the forecast period 2020 – 2025. 

The study indicates that, players in the Cancer Immunotherapy market space can expect a marginal rise in the demand for Cancer Immunotherapy, with an estimated CAGR of 15% during the forecast period. Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections of the Cancer Immunotherapy market, both at global and regional levels. The analysts have used numerous industry-wide prominent business intelligence tools to consolidate facts, figures, and market data into revenue estimations and projections in the Cancer Immunotherapy market. 

After reading the Cancer Immunotherapy market report, readers get insight into: 

The global colorectal cancer diagnostics market is anticipated to exhibit an impressive expansion at a CAGR of 8.5% during the forecast period 2017 to 2022, according to a report by Fact.MR. Global revenues from the market is projected to surpass US$ 2,000 Mn by 2022-end.

According to the World Cancer Research Fund, colorectal cancer forms the third-most occurring type of cancer across the globe. In 2012, over 1 Mn cases of colorectal cancer were diagnosed. Majority of these cases were reported across developed economies, and this is further estimated to exceed in the near future. This rise in incidences of colorectal cancer has boosted demand for its diagnostics, treatment, and therapeutics worldwide. However, the number of deaths owing to colorectal cancer has been witnessing a decline since recent past, owing to the awareness spread by the American Cancer Society. The introduction of more effective diagnostics, and development of screening methods are further expected to drive growth of the global colorectal cancer diagnostics market.

Request for Sample Report with Statistical info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=70